Go Back

Cardiovascular case study: Global Phase III Study – Heart Failure & Actigraphy

18 May 2017

After case studies about autoimmune & skin diseases, psoriasis and oncology, Kayentis releases its cardiovascular case study regarding heart failure and actigraphy. Kayentis offers combined eCOA / ePRO expertise in cardiovascular and medical device.

Global Phase III study – Cardiovascular & heart failure

  • 600 patients
  • 150 sites
  • 20 countries
  • 26 languages

Challenges of the cardiovascular case study

  • An eCOA partner that could deliver an ePRO solution combined with proven data management and actigraphy expertise.
  • On-site ePRO solution and data management of actigraphy data.
  • Short study set-up timelines and interaction with the sponsor and different CROs for study implementation.

Frédérique MARION, Kayentis Business Development Director – May, 18, 2017

To download this case study, please click here:

Kayentis ePRO cardiovascular case study

Last update: 2018, January


  • 17 April
    DIA Europe - from 17th to 19th April, Basel - Switzerland Schedule a meeting with Kayentis DIA Europe Basel, Switzerland
  • 15 May
    OCT Europe - 15th & 16th May – Barcelona, Spain Schedule a meeting with Kayentis OCT Europe Barcelona
  • Follow us

    Download our brochure